EUVIMEDEUVIMED entdecken
Crossref

Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae , From Türkiye

Neslihan Akdogan iD, Mustafa Kamer Kaymak iD, Cemre Bosnak iD, Meliha Cağla Sonmezer iD, Dolunay Gulmez iD, Ceylan Polat iD, Sevtap Arikan Akdagli iD

International Journal of Dermatology · 2026

DOI: 10.1111/ijd.70236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2026. Verfasst von Neslihan Akdogan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Department of Dermatology and Venereology, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Antifungal Agents, Tinea, Trichophyton. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trichophyton indotineae is a global cause of dermatophytosis resistant to terbinafine and sometimes systemic azoles. We describe clinical features, treatment outcomes, and antifungal susceptibility in 13 DNA‐confirmed cases.

Methods

This retrospective study included 32 treatment cycles in 13 T. indotineae patients in Türkiye. Skin scrapings were cultured and identified by matrix‐assisted laser desorption time of flight‐mass spectrometry, with confirmation by internal transcribed spacer and the large subunit rRNA sequencing followed by phylogenetic analysis. Antifungal susceptibility testing and detection of squalene epoxidase (SQLE) gene mutations were performed using agar screening and EUCAST microdilution methods.

Results

Thirteen immunocompetent patients (M/F: 7/6, mean age 40.3 ± 13.8 years) presented with widespread plaques. The median times to rash onset and diagnosis were 7 months and 8 months, respectively. Nine patients had previously failed standard‐dose oral terbinafine. Among 32 antifungal treatment cycles (30 systemic, 2 topical) outcomes included 21 complete remissions (CR), 4 partial remissions (PR), 7 nonresponses, 3 adverse events, with 3 relapses, and 9 recurrences. By final follow‐up, 12 patients achieved CR—with itraconazole, voriconazole, and fluconazole—while 1 had PR. Clinical responses to itraconazole and voriconazole generally aligned with the minimal inhibitory concentrations (MICs), whereas reactions to fluconazole did not. SQLE mutations were present in isolates with high terbinafine MICs but absent in those with low MICs.

Discussion

CR was strongly associated with itraconazole, followed by voriconazole and fluconazole. Treatment outcomes didn't always match with MICs, suggesting prolonged treatment and nontraditional agents like voriconazole and posaconazole may be required. Clinicians should be vigilant in diagnosing and managing T. indotineae .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsTineaTrichophytonHumansFemaleAdultRetrospective StudiesMaleMiddle AgedMicrobial Sensitivity TestsDrug Resistance, FungalTreatment OutcomeSqualene MonooxygenaseItraconazoleYoung AdultMutationVoriconazoleRecurrenceTerbinafineFluconazoleTriazolesRemission Induction

Stichwörter der Autor:innen

Trichophyton indotineaeSQLE mutationantifungal susceptibilityfluconazoleitraconazoleminimum inhibitory concentrationposaconazoleresistanceterbinafinevoriconazole

Substanzen

Antifungal AgentsSqualene MonooxygenaseItraconazoleVoriconazoleTerbinafineFluconazoleTriazolesposaconazole

Autor:innen und Institutionen

  • School of Medicine, Department of Dermatology and Venereology, Hacettepe University, Ankara, Turkey.
  • School of Medicine, Department of Infectious Diseases, Hacettepe University, Ankara, Turkey.
  • School of Medicine, Department of Medical Microbiology, Hacettepe University, Ankara, Turkey.

ORCID-Profile: Neslihan Akdogan, Mustafa Kamer Kaymak, Cemre Bosnak, Meliha Cağla Sonmezer, Dolunay Gulmez, Ceylan Polat, Sevtap Arikan Akdagli

Zitieren

APA

Akdogan, N., Kaymak, M. K., Bosnak, C., Sonmezer, M. C., Gulmez, D., Polat, C., & Akdagli, S. A. (2026). Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae , From Türkiye. International Journal of Dermatology. https://doi.org/10.1111/ijd.70236

Vancouver

Akdogan N, Kaymak MK, Bosnak C, Sonmezer MC, Gulmez D, Polat C, et al. Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae , From Türkiye. International Journal of Dermatology. 2026. doi:10.1111/ijd.70236

BibTeX
@article{Akdogan2026,
  author = {Akdogan, Neslihan and Kaymak, Mustafa Kamer and Bosnak, Cemre and Sonmezer, Meliha Cağla and Gulmez, Dolunay and Polat, Ceylan and Akdagli, Sevtap Arikan},
  title = {Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae , From Türkiye},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.70236}
}
Kostenlos starten →